Tofacitinib in antisynthetase syndrome-related rapidly progressive interstitial lung disease - Sorbonne Université
Journal Articles Rheumatology Year : 2020

Tofacitinib in antisynthetase syndrome-related rapidly progressive interstitial lung disease

No file

Dates and versions

hal-03104606 , version 1 (09-01-2021)

Identifiers

Cite

Marc Pineton de Chambrun, Baptiste Hervier, Simon Chauveau, Yacine Tandjaoui-Lambiotte, Alain Combes, et al.. Tofacitinib in antisynthetase syndrome-related rapidly progressive interstitial lung disease. Rheumatology, 2020, 59 (12), pp.e142-e143. ⟨10.1093/rheumatology/keaa323⟩. ⟨hal-03104606⟩
21 View
0 Download

Altmetric

Share

More